皇家华人

header-logo
Research Collaborate Lab Hall
headshot

Anita D'Souza, MD

Associate Chief, Research, Division of Hematology/Oncology; Professor of Medicine

view physician profile

Locations

  • Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English, Hindi

Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

Anita D’Souza, MD, MS completed medical school in Goa Medical College, India where she graduated at the top of her class and was voted Best Medical Graduate. She completed her Hematology and Medical Oncology fellowship at the Mayo Clinic, Minnesota.

Research Interests

Dr. D'Souza's clinical and research work is focused on plasma cell cancers (e.g. multiple myeloma, AL amyloidosis, POEMS syndrome, Waldenstrom Macroglobulinemia) and the use of hematopoietic cell transplantation to treat these diseases. She serves as a scientific director of the Plasma Cell Disorders and Adult Solid Tumors working committee in the Center for International Blood and Marrow Transplant Research (CIBMTR). She is principal investigator on clinical trials in amyloidosis and multiple myeloma. She is a recipient of the 2016 KL2 Career Development Award from the Clinical and Translational Science Institute. Dr. D’Souza is board certified in Internal Medicine, Hematology and Medical Oncology.

Publications

  • (Chakraborty R, Zanwar S, Hegenbart U, Bhutani D, Gertz MA, Dispenzieri A, Kumar S, D'Souza A, Patwari A, Cowan A, Chen G, Milani P, Palladini G, Sanchorawala V, Bodanapu G, Schönland SO, Lentzsch S, Muchtar E.) Blood. 2024 Dec 19;144(25):2613-2624 PMID: 39197073 08/29/2024

  • (Yohay S, Oloyede T, Kim S, Fang X, Dhakal B, Aijaz A, Mohan M, Narra R, Pasquini M, D'Souza A, Hamadani M, Freeman CL, Akhtar OS.) Br J Haematol. 2024 Dec;205(6):2370-2375 PMID: 39396814 SCOPUS ID: 2-s2.0-85206072300 10/14/2024

  • (Akhtar OS, Arshad S, Lian Q, Ahn KW, D'Souza A, Dhakal B, Mohan M, Pasquini M, Longo W, Shah NN, Fenske TS, Hamadani M.) Transplant Cell Ther. 2024 Dec;30(12):1191.e1-1191.e8 PMID: 39303985 SCOPUS ID: 2-s2.0-85206435293 09/21/2024

  • (Wu JF, Estrada-Merly N, Dhakal B, Mohan M, Narra RK, Pasquini MC, D'Souza A.) Transplant Cell Ther. 2024 Dec;30(12):1189.e1-1189.e10 PMID: 39277111 SCOPUS ID: 2-s2.0-85205846893 09/15/2024

  • (Estrada-Merly N, Maurer MS, D'Souza A.) Amyloid. 2024 Dec;31(4):339-341 PMID: 39004806 PMCID: PMC11598661 07/15/2024

  • (Akhtar OS, Szabo A, Bhatlapenumarthi V, Forsberg M, Balev M, Patwari A, Cheruvalath H, Bhutani D, Thanendrarajan S, Dhakal B, Zangari M, Patel T, Shrestha A, Al-Hadidi S, Cooper D, Lentzsch S, van Rhee F, Shah MR, Bag A, D'Souza A, Schinke C, Chakraborty R, Shah N, Mohan M.) Br J Haematol. 2024 Nov;205(5):1830-1834 PMID: 39192546 SCOPUS ID: 2-s2.0-85202177578 08/28/2024

  • (Hagen P, D'Souza A.) Blood Rev. 2024 Nov;68:101228 PMID: 39179452 PMCID: PMC11568934 08/24/2024

  • (Kim M, Arabi J, McCoy C, D'Souza A, Chhabra S, Abid MB, Thapa B, Dhakal B.) Clin Lymphoma Myeloma Leuk. 2024 Nov;24(11):804-807 PMID: 39043500 SCOPUS ID: 2-s2.0-85200365330 07/24/2024

  • (Akinola I, Flynn KE, Szabo A, Finkel M, D'Souza A.) Amyloid. 2024 Sep;31(3):235-237 PMID: 38764391 PMCID: PMC11330728 SCOPUS ID: 2-s2.0-85193705751 05/20/2024

  • (Furqan F, Bhatlapenumarthi V, Dhakal B, Fenske TS, Farrukh F, Longo W, Akhtar O, D'Souza A, Pasquini M, Guru Murthy GS, Runaas L, Abedin S, Mohan M, Shah NN, Hamadani M.) Blood Adv. 2024 Aug 27;8(16):4320-4329 PMID: 38889435 PMCID: PMC11372811 SCOPUS ID: 2-s2.0-85203009004 06/18/2024

  • (Chakraborty R, Cheruvalath H, Patwari A, Szabo A, Schinke C, Dhakal B, Lentzsch S, D'Souza A, Mohyuddin GR, Julian K, Midha S, Costello P, Kaiser M, Hing MNL, Harrison SJ, Cliff ERS, Mohan M.) Blood Cancer J. 2024 Aug 12;14(1):137 PMID: 39134535 PMCID: PMC11319778 SCOPUS ID: 2-s2.0-85201250452 08/13/2024

  • (Singh A, Szabo A, Lian Q, Pezzin L, Sparapani R, D'Souza A.) Blood Cancer J. 2024 May 26;14(1):61 PMID: 38796476 PMCID: PMC11127981 SCOPUS ID: 2-s2.0-85194268737 05/26/2024

Publications of Anita D'Souza MD from the

© 2025 皇家华人.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.